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Methicillin-resistant Staphylococcus aureus (MRSA) is associated 
with increased mortality and morbidity and a leading cause of 
hospital-acquired infections.  Community-acquired (CA)-MRSA are 
a growing concern worldwide. In the last 10 years, an increase in 
the MRSA rate from 2% to approximately 23% has been observed 
in Germany, while a rate under 5% has been recorded for many 
years in the Netherlands and Scandinavia. In the Netherlands in 
particular, MRSA rates have become very low in stationary care 
due to a consistent ‘search and destroy’ policy. The main focus in 
Germany lies on hospital-acquired MRSA, whereas the Netherlands 
focus on the control of the importation of MRSA cases from abroad 
and on CA-MRSA. As MRSA in hospitals and in the community 
can be a problem in cross-border health care, the European 
Union-funded EUREGIO MRSA-net project was established in 
the bordering regions Twente/Achterhoek, the Netherlands and 
Münsterland, Germany. The main aim of the project is the creation 
of a network of the major health care providers in the EUREGIO 
and the surveillance and prevention of MRSA infections. A spa-
typing network was established in order to understand the regional 
and cross-border dissemination of epidemic and potentially highly 
virulent MRSA genotypes. As the reduction of differences in health 
care quality is an important prerequisite for cross-border health 
care,  a transborder quality group comprising hospitals, general 
practitioners, public health authorities, laboratories, and insurerance 
companies has been established since 2005 equalising the quality 
criteria for the control of MRSA on both sides of the border. 
Introduction
Staphylococcus aureus is responsible for the majority of 
healthcare-associated infections worldwide. These infections 
include skin and mucosa infections, pneumonia and septicaemia. 
Infections caused by methicillin-resistant S. aureus (MRSA) are 
particularly critical because the therapeutic options are limited. 
Consequently, infections with MRSA are associated with a higher 
morbidity and lethality compared to other staphylococci. In the 
past ten years, an increase in the prevalence of MRSA infections 
has been observed in Germany. Although it has been assumed 
that the rate of MRSA isolations from blood cultures in Germany 
has stabilised at a level around 20-30%, this is still significantly 
higher than in neighbouring countries such as The Netherlands and 
Denmark, where the rates have been around 1% for many years 
[1]. This is a clear signal that the MRSA rates in hospitals can be 
minimised by adopting a consistent and co-ordinated “search and 
destroy” approach [2].
The EUREGIO MRSA-net project is a regional network designed 
to protect the population in the Dutch-German border region Twente/
Münsterland (Figure 1) against MRSA infections [3,4]. It was 
launched to improve the implementation of MRSA prevention and 
control strategies within the EUREGIO by exchanging knowledge 
and technology. It represents a regional network for the control of 
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MRSA involving local healthcare providers as recommended by the 
conference of the Germany’s state health ministers in Dessau in 
June 2006. In Germany, the project is being co-ordinated by the 
Institute for Hygiene at the University Hospital Münster and the 
State Institute for Health and Work in North Rhine-Westphalia. 
In the Netherlands, it is co-ordinated by the laboratory Twente-
Achterhoek and the University of Twente in Enschede.
Methods
The major objective of the EUREGIO MRSA-net project is to to 
improve patient safety and cross-border patient exchange in the 
EUREGIO. Its main activities are:
1. The creation of a euregional and cross-border network in the 
EUREGIO: 74 coordinator meetings, 21 round table discussions 
and four general meetings of all hospitals in the area have been 
organised to date; 
2. Prevalence screening on admission of the patient to hospital 
and evaluation of regional risk factors: Over a four week period 
in November 2006, all patients in all participating hospitals 
in the region were screened at admission and asked for MRSA-
associated risk factors; 
3. Development of an MRSA prevention and control concept: 
Comparison and matching of recommended hygiene standards 
in the region [4,5]; 
4. Establishment of an international web-based communication 
portal for handling MRSA problems (24-hour help desks) for 
healthcare workers, patients and the public [5]; 
5. Training and professional development of healthcare personnel: 
146 seminars and presentations for staff have been arranged 
to date; 
6. Creating public awareness for MRSA and infections in general: 
The project was presented in 16 reports on national and regional 
television, seven radio reports and 45 contributions to local and 
national press; 
7. Construction of an online spa-typing network for an early warning 
system.
Altogether, 40 hospitals in a region covering 8,000 km² and 
comprising 2.7 million inhabitants (950,000 inhabitants in the 
Dutch area) have participated in the project so far (Table 1). The 
healthcare structures in the EUREGIO vary strongly between the 
Dutch and the German side of the border: While on the German 
side there are six patient beds per 1,000 inhabitants, there are 
two patient beds per 1,000 inhabitants on the Dutch side. The 
same applies to doctors working outside hospitals. 163 doctors 
per 100,000 inhabitants (50% general practitioners (GPs) and 
50% specialists) work in the Münsterland area compared to about 
43 GPs per 100,000 inhabitants in the project area inTwente/
Achterhoek. 
The EUREGIO project involves 40 hospitals (four in the Dutch 
part), eight regional microbiological laboratories (one in the Dutch 
part), six public health offices (one in the Dutch part), and five 
professional institutions (e.g. Medical Order, Medical Association, 
health insurances such as the AOK Westphalia-Lippe). Patient 
interests regarding the quality of cross-border health were taken 
into account through collaboration with EPECS (European Patient 
Empowerment for Customised Solutions). In addition, nursing 
homes, ambulatory nursing services, and patient transportation 
services were included. The validation of special microbiological 
diagnostic procedures to detect MRSA was carried out by the 
Institute of Medical Microbiology at the University Hospital of 
Münster. 
Results and discussion 
Creating a crossborder network
The different actors involved in healthcare in the area were 
invited to round table discussions and informed about the project 
on several occasions. The motto for these round table discussions 
was “MRSA: One border, one problem, two results”. The discussions 
showed that post-discharge case management of MRSA patients 
was not done regularly on the German side. Therefore, a 12-month-
long case management system was established that required GPs to 
T a b l e  1
Comparison of healthcare structures between the Dutch and the 
German bordering regions in the EUREGIO MRSA-net Twente/
Münsterland, 2006
EUREGIO MRSA-net 
Dutch part
(Twente)
EUREGIO MRSA-net  
German part 
(Münsterland)
No. of inhabitants 950,000 1,700,000
No. of acute care hospitals 4 33
No. of patient beds 2,200 10,139
Hospital patient beds/1,000 
inhabitants 2 6
No. general practices (and 
specialists only in the 
German part)
358 3,128
General practices/1,000 
inhabitants 0.4 1.8
No. of public health 
service offices 1 5
F i g u r e  2
MRSA decolonisation planning tool for planning the 12-month-long 
case management period in hospitals and ambulatory care on the 
German side of the EUREGIO MRSA-net 
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recall a patient twice to control their colonisation status, first three 
to six months and again 12 months after discharge from hospital. 
Only after 12 months of negative screening results was a patient 
to be considered MRSA-negative, Patients admitted to a hospital 
during that period need to be screened before admission or isolated 
until they are excluded as persistent carriers of MRSA. 
In order to improve the communication between hospitals and 
GPs, an MRSA patient management checklist was developed as 
well as a decolonisation planning tool (Figure 2) that facilitates the 
planning of the 12-month case management. The checklist informs 
the GP about the MRSA patient’s condition at the time of hospital 
discharge and the treatment steps needed for his decolonisation. 
As consistent protocols for infection control outside the hospitals 
did not exist on the German side, such protocols were developed 
for patient transport services, nursing homes, ambulatory care.
Following the Dutch example of controlled decolonisation 
also after stationary care, an agreement was achieved between 
the Association Of Statutory Health Insurance for physicians 
(Kassenärztliche Vereinigung Westfalen-Lippe (KVWL)) and the 
primary health insurances (especially the AOK Westfalen-Lippe) 
regarding payment for GP services. According to this agreement, 
preventive decolonisation and control screening are now possible 
in ambulatory care after discharge from hospital and thus before 
next hospitalisation of the patient.
Finally, the public health offices were involved in the 
development of the network from the beginning. Acting within 
the scope of national legislation, the five German public health 
offices participated in the project as external quality controllers for 
all health institutions in the region. In order to make the regional 
MRSA epidemiology comparable, the hospitals were provided with 
the EpiMRSA software (Ridom GmbH, Würzburg) which enabled 
them to collect relevant data for standardised and cross-border 
analysis of MRSA-associated data (e.g. MRSA incidence, swabbing 
frequency and infection rates, spa types). These comparable 
data were regularly collected from all hospitals by the German 
public health offices, which allows for a better comparability and 
sustainability [5]. 
Prevalence screening and risk factor analysis
In November 2006, the MRSA-net project screened, during 
a four-week period, 86% of all inpatient admissions to German 
hospitals in the EUREGIO and interviewed all patients with 
regard to risk factors. This four-week prevalence screening was 
established in order to validate the already established screening 
recommendations. Preliminary analysis of the data indicates that 
the prevalence of MRSA varies between different districts and 
between different hospitals within the region. 
Prevalence screening was also performed in one of the four 
Dutch hospitals in the EUREGIO. MRSA admission prevalence 
was shown to be about three-fold lower than on the German side 
of the border. Panton-Valentine leukocidin-producing community-
acquired (CA)-MRSA infections only rarely contribute to the MRSA 
admission burden of regional hospitals (Netherlands: 8%, Germany: 
<1%). On the German side, the screening programme following 
the current national guidelines would have detected less than 
50% of the MRSA carriers that were identified in our prevalence 
screening exercise. Screening of patients with a history of previous 
hospitalisation (not only in foreign “high-prevalence” countries, 
but also in German facilities) is therefore of great importance for 
successful MRSA detection for the hospitals in the EUREGIO. 
Following this period of prevalence screening, MRSA prevention 
strategies and screening indications were adapted to a common 
euregional standard in all participating hospitals. 
Prevention via the development of a web-based communication 
system for MRSA
The most important instruments needed to successfully implement 
prevention strategies and control measures are application plans 
and target group-specific infection control protocols. 
We carried out 28 application tests with different target groups 
(doctors, nursing staff, and ward assistants) and examined infection 
control protocols of different hospitals on both sides of the border. 
The tests showed that information in the protocols was too difficult 
to understand or incomplete, or was not provided at all [6,7]. The 
tests also brought up over 160 practical questions about MRSA, 
to which the established infection control protocols and national 
guidelines did not provide answers.
We have developed a target group-oriented, user-friendly web-
based portal. and practical questions and answers about MRSA. 
The national guidelines of the German Robert Koch Institute (RKI) 
and of the Dutch Working Group for Infection Prevention (WIP) 
provide the basis for the bi-lingual portal [8]. It can be accessed 
via www.mrsa-net.nl.
Further education and professional development
In order to create sustainable structures, more than 140 training 
courses have been organised to date for healthcare professionals 
in the EUREGIO. The medical association, the KVWL, the local 
doctors’ association, and quality circles worked together to provide 
and carry out a series of professional educational courses for GPs 
and regional pharmacotherapy consultants. Regular analysis of the 
antibiotic prescriptions from all doctors in ambulatory care was 
established on the German side, following the Dutch experience.
Public Awareness
All information about the project is arranged according to target 
group and can be called up on the MRSA-net homepage. An around 
the clock “MRSA-net helpdesk” has been established in 2005. On 
average, more than 200 phone calls are registered per month by 
the helpdesk (80% of them on the German side). Two thirds of the 
phone calls come from health professionals seeking information 
about how to handle MRSA patients, and one third of the calls 
from patients or their relatives asking for general information about 
MRSA, its transmission in home settings, and the possible health 
risks for household contacts. 
Leaflets and posters on the subject are available for patients 
and their relatives in printed or electronic form. The project has 
also been presented in a number of media reports (for details visit 
www.mrsa-net.eu). High priority is given to a systematic publicity 
campaign, because, especially in Germany, people feel they are not 
adequately informed about the MRSA problem. 
EUREGIO MRSA-net spa-typing network
The Institute of Hygiene in Münster has developed a sequence-
based typing strategy [9-11] that enables the online and real-time 
comparison of laboratory typing data on a region-wide and cross-
border level for the first time. This method, which is based on 
spa typing, is used as a ‘common laboratory language’, elucidates 
epidemiologic correlations and helps to construct a molecular 
surveillance system [12]. 
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Thirty-two hospitals in the EUREGIO (including four Dutch 
hospitals) agreed to spa-type the first MRSA-isolate from every 
patient. Five others spa-type MRSA from blood culture and in case 
of clusters. Furthermore, spa-typing data is collected and exchanged 
via the common server. On the German side, 20 sentinel GPs for 
CA- MRSA were encouraged to collect swabs from patients with 
soft tissue infections and send them to the euregional laboratories 
to be spa-typed. The typing data (i.e. regional distribution of spa 
types and occurrence of new types) have been analysed regionally 
and on both sides of the border since the project began. Table 2 
shows the most prevalent spa types found in the EUREGIO. 
On the one hand, it has been shown that certain spa types 
occur on both sides of the border. A comparison with data from 
the international typing initiative SeqNet.org (http://www.seqnet.
org) has demonstrated that these types can also be found in other 
European countries and that they belong to ‘epidemic’ clonal 
lineages (e.g. t032, t003, t001). These types are also found all 
over the EUREGIO. 
On the other hand, however, significant differences in the 
molecular epidemiology of MRSA have been found on both sides 
of the border (e.g. t026). These differences are illustrated in an 
online geographic analysis tool (Figure 3).
An early warning system based on a Z-Score analysis of current 
and historical spa-typing data [13] was designed to identify an 
unusual accumulation of specific MRSA spa types, which are 
considered to be particularly epidemic or virulent (Figure 4).
Conclusion
Because of the success of the EUREGIO MRSA-net in 
establishing regional and local measures against MRSA (see Box), 
the Robert Koch Institute considers this project as a prototype for 
regional networks dealing with infectious disease issues [4,5]. 
The differences in the prevalence of MRSA between Germany and 
T a b l e  2
MRSA prevalence and spa types in the EUREGIO Twente/
Münsterland* between July 2005 and June 2006
EUREGIO MRSA-net 
Dutch part
EUREGIO MRSA-net 
German part
Number of MRSA 54 1,034
Predominant spa types 
t002, t012, t019, 
t026, t044, t065 
(accounting for 
87% of all MRSA)
t003, t032, t004, 
t011, t008  
(accounting for 
78% of all MRSA)
No. of PVL-positive MRSA (% of 
all MRSA), (associated spa types)
5 (8.3%), 
(t044, t016)
5 (0.6%), 
(t044, t019, t437) 
MRSA: methicillin-resistant Staphylococcus aureus; PVL: Panton-Valentine 
leukocidin.
* isolates obtained in 33 regional German acute care hospitals and four 
regional Dutch acute care hospitals 
F i g u r e  3
Online geographic illustration database showing the incidence rates 
(per 100,000 inhabitants) of MRSA spa types (here t032) isolated 
from patients in the hospitals of the EUREGIO MRSA-net Twente/
Münsterland
F i g u r e  4
spa type-based barometer for the identification of newly imported 
or emerging spa types as surrogate markers for highly epidemic or 
virulent clones in the EUREGIO
B o x
Milestones achieved of the EUREGIO MRSA-net Twente/
Münsterland
Creation a cross-border MRSA network of all institutions involved in 1. 
healthcare in the Münsterland/Twente region;
Comparison of national guidelines and creation of workable and user-2. 
friendly MRSA infection control protocols;
Further education and professional development of healthcare staff;3. 
Enhancement of public awareness towards MRSA and prevention of 4. 
infectious diseases in general by (regional) media reports;
Establishment of a 5. spa-typing network for comparable molecular 
surveillance of MRSA and CA-MRSA in the EUREGIO;
Close co-operation with public health offices (Öffentlicher 6. 
Gesundheitsdienst in Germany and Geneeskundige en Gezondheidsdienst 
in The Netherlands);
Creation of a quality euregional health net (with quality seal) and the 7. 
creation of structures necessary to achieve a long-term decrease in 
the MRSA rate in the EUREGIO.
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the Netherlands are considerable and have led to problems in 
cross-border healthcare activities and treatment of patients in the 
German-Dutch border region. However, the exchange of know-how 
and experience in MRSA management will improve the quality of 
patient treatment on both sides of the border and can provide an 
advantage for the people living in the border regions. 
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